Melissa Ronan

22PUBLICATIONS
339CO-AUTHORS
Molecular targetsPredictive and prognostic markersCheminformatics and quantitative structure-activity relationshipsNeural engineeringCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|May 22, 2026
Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multi-Selective Inhibitors in NRAS-Mutated Melanoma.

|Oct 27, 2025
PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical Models.

Dejan Juric, Kyung Song, Radia M Johnson

|Oct 03, 2025
Targeting histone H2B acetylated enhanceosomes via p300/CBP degradation in prostate cancer.

Jie Luo, Zhixiang Chen, Yuanyuan Qiao

|Sep 03, 2025
An allele-agnostic mutant-KRAS inhibitor suppresses tumor maintenance signals and reprograms tumor immunity in pancreatic cancer.

Kathleen M McAndrews, Francesca Paradiso, Clint A Stalnecker

|Jul 24, 2025
A neomorphic protein interface catalyzes covalent inhibition of RASG12D aspartic acid in tumors.

Caroline Weller, G Leslie Burnett, Lingyan Jiang

|Jun 02, 2025
KDM4C inhibition blocks tumor growth in basal breast cancer by promoting cathepsin L-mediated histone H3 cleavage.

Zheqi Li, Guillermo Peluffo, Laura E Stevens

Pageof 4

Frequent Collaborators

22 joint publications

Jennifer Roth

21 joint publications

Matthew Rees

6 joint publications

Andrew S Boghossian

4 joint publications

Jacqueline A M Smith